GLP-1 receptor agonists × glycemic control

TrialDiabetes, obesity & metabolism2021

Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge.

Francisco J Pasquel et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 273 people · 2021

Range includes no effect

No clear effect on glycemic control

−0.28percentage points−0.64 to +0.09

As reported

difference −0.28 %, 95% CI −0.64 to 0.09

One number in the abstract

the abstract, start to end

in HbA1c at 12 weeks and 26 weeks was -0.28% (95% CI -0.64, 0.09), and at

← favours treatmentfavours comparator →
could be chance
Glycemic control
−0.28−0.64 to 0.09
GLP-1 receptor agonistsGlycemic control
1 / 3

13 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33591621